Similarly, it is well-known that in various cancers, gene mutations and dysregulation occur in Kras/mitogen-activated protein kinase (MAPK) and phosphatidylinositol-3 kinase (PI3K)/Akt/mTOR, which are signal transduction pathways related to glycolysis control [26,43]. This evidence concerns the gene KRAS and cancer.